SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'G39'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.68A | 1a4gA-4b7jA:53.0 | 1a4gA-4b7jA:31.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.46A | 1a4gA-4b7jA:53.0 | 1a4gA-4b7jA:31.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.65A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.47A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.06A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.71A | 1a4gA-4yw5A:23.8 | 1a4gA-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_A_ZMRA466_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.39A | 1a4gA-6eksA:13.8 | 1a4gA-6eksA:19.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_A_ZMRA466_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.16A | 1a4gA-4hzzA:52.3 | 1a4gA-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.66A | 1a4gB-4b7jA:53.0 | 1a4gB-4b7jA:31.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.67A | 1a4gB-4hzzA:52.2 | 1a4gB-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.52A | 1a4gB-4hzzA:52.2 | 1a4gB-4hzzA:33.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.03A | 1a4gB-4hzzA:52.2 | 1a4gB-4hzzA:33.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.41A | 1a4gB-4yw5A:23.9 | 1a4gB-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A4G_B_ZMRB466_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 1a4gB-6eksA:13.6 | 1a4gB-6eksA:19.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1A4G_B_ZMRB466_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ILE A 222 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 ( 4.1A) | 0.19A | 1a4gB-4hzzA:52.2 | 1a4gB-4hzzA:33.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F9G_A_ASCA950_0 (HYALURONATE LYASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 7 | ARG A 152ASN A 295ARG A 368ARG A 118 | G39 A1470 (-3.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-3.1A) | 1.40A | 1f9gA-4b7jA:undetectable | 1f9gA-4b7jA:19.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 179ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)NoneNoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.42A | 1l7fA-4b7jA:64.5 | 1l7fA-4b7jA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.21A | 1l7fA-4hzzA:63.2 | 1l7fA-4hzzA:48.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7F_A_BCZA801_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ASP A 276TRP A 337GLU A 645ARG A 661TYR A 766 | G39 A 908 (-3.3A)NoneG39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 0.60A | 1l7fA-6eksA:20.8 | 1l7fA-6eksA:17.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 368 | G39 A1470 (-3.1A)G39 A1470 (-3.9A)G39 A1470 (-3.0A) | 0.20A | 1l7fA-4b7jA:64.5 | 1l7fA-4b7jA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7F_A_BCZA801_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | G39 A 509 (-3.0A)G39 A 509 (-3.9A)G39 A 509 (-2.9A) | 0.19A | 1l7fA-4hzzA:63.2 | 1l7fA-4hzzA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 179ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.28A | 1l7gA-4b7jA:64.4 | 1l7gA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292TYR A 406 | NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.21A | 1l7gA-4hzzA:63.1 | 1l7gA-4hzzA:48.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1L7G_A_BCZA801_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ASP A 276TRP A 337GLU A 645ARG A 661TYR A 766 | G39 A 908 (-3.3A)NoneG39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 0.58A | 1l7gA-6eksA:20.7 | 1l7gA-6eksA:17.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 179ARG A 225GLU A 228GLU A 277GLU A 278TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)NoneNoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-4.5A) | 0.44A | 1l7hA-4b7jA:64.4 | 1l7hA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224GLU A 227GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.19A | 1l7hA-4hzzA:63.2 | 1l7hA-4hzzA:48.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 368 | G39 A1470 (-3.1A)G39 A1470 (-3.9A)G39 A1470 (-3.0A) | 0.21A | 1l7hA-4b7jA:64.4 | 1l7hA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1L7H_A_BCZA801_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ARG A 152ARG A 371 | G39 A 509 (-3.0A)G39 A 509 (-3.9A)G39 A 509 (-2.9A) | 0.17A | 1l7hA-4hzzA:63.2 | 1l7hA-4hzzA:48.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 152ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.9A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.60A | 1nncA-4b7jA:64.0 | 1nncA-4b7jA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.14A | 1nncA-4b7jA:64.0 | 1nncA-4b7jA:40.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.62A | 1nncA-4hzzA:62.7 | 1nncA-4hzzA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.87A | 1nncA-4hzzA:62.7 | 1nncA-4hzzA:48.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 152ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.45A | 1nncA-4hzzA:62.7 | 1nncA-4hzzA:48.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.52A | 1nncA-4yw5A:20.3 | 1nncA-4yw5A:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NNC_A_ZMRA479_1 (NEURAMINIDASE N9) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.39A | 1nncA-6eksA:20.5 | 1nncA-6eksA:17.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1NNC_A_ZMRA479_2 (NEURAMINIDASE N9) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A) | 0.15A | 1nncA-4hzzA:62.7 | 1nncA-4hzzA:48.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_A_ZMRA1200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 10 | TYR A 533TYR A 553GLU A 584ARG A 600ARG A 662 | G39 A 801 (-4.5A)NoneG39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A) | 0.69A | 1v3eA-4yw5A:4.6 | 1v3eA-4yw5A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_A_ZMRA1200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 10 | TYR A 553PHE A 396GLU A 584ARG A 600ARG A 662 | NoneG39 A 801 (-3.9A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A) | 1.06A | 1v3eA-4yw5A:4.6 | 1v3eA-4yw5A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_B_ZMRB2200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 10 | ARG A 290TYR A 533TYR A 553GLU A 584ARG A 600 | G39 A 801 (-2.6A)G39 A 801 (-4.5A)NoneG39 A 801 ( 4.7A)G39 A 801 (-2.9A) | 1.04A | 1v3eB-4yw5A:7.7 | 1v3eB-4yw5A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_B_ZMRB2200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 10 | ARG A 290TYR A 533TYR A 553GLU A 584TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-4.5A)NoneG39 A 801 ( 4.7A)G39 A 801 (-4.4A) | 0.96A | 1v3eB-4yw5A:7.7 | 1v3eB-4yw5A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_B_ZMRB2200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 10 | TYR A 533TYR A 553GLU A 584ARG A 600ARG A 662 | G39 A 801 (-4.5A)NoneG39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A) | 0.68A | 1v3eB-4yw5A:7.7 | 1v3eB-4yw5A:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V3E_B_ZMRB2200_1 (HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 10 | TYR A 553PHE A 396GLU A 584ARG A 600ARG A 662 | NoneG39 A 801 (-3.9A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A) | 1.09A | 1v3eB-4yw5A:7.7 | 1v3eB-4yw5A:21.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.65A | 2cmlA-4b7jA:64.2 | 2cmlA-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.47A | 2cmlA-4b7jA:64.2 | 2cmlA-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.63A | 2cmlA-4hzzA:63.0 | 2cmlA-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.41A | 2cmlA-4hzzA:63.0 | 2cmlA-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.88A | 2cmlA-4hzzA:63.0 | 2cmlA-4hzzA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.71A | 2cmlA-4yw5A:10.2 | 2cmlA-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_A_ZMRA1477_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.44A | 2cmlA-6eksA:20.9 | 2cmlA-6eksA:21.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.23A | 2cmlA-4b7jA:64.2 | 2cmlA-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_A_ZMRA1477_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.15A | 2cmlA-4hzzA:63.0 | 2cmlA-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.58A | 2cmlB-4b7jA:64.1 | 2cmlB-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.55A | 2cmlB-4hzzA:62.8 | 2cmlB-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.38A | 2cmlB-4hzzA:62.8 | 2cmlB-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.85A | 2cmlB-4hzzA:62.8 | 2cmlB-4hzzA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.71A | 2cmlB-4yw5A:4.5 | 2cmlB-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_B_ZMRB2477_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 2cmlB-6eksA:10.1 | 2cmlB-6eksA:21.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.27A | 2cmlB-4b7jA:64.1 | 2cmlB-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_B_ZMRB2477_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.18A | 2cmlB-4hzzA:62.8 | 2cmlB-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.63A | 2cmlC-4b7jA:64.1 | 2cmlC-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.49A | 2cmlC-4b7jA:64.1 | 2cmlC-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.59A | 2cmlC-4hzzA:62.9 | 2cmlC-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.44A | 2cmlC-4hzzA:62.9 | 2cmlC-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.88A | 2cmlC-4hzzA:62.9 | 2cmlC-4hzzA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.72A | 2cmlC-4yw5A:2.9 | 2cmlC-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_C_ZMRC3477_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.43A | 2cmlC-6eksA:10.0 | 2cmlC-6eksA:21.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.31A | 2cmlC-4b7jA:64.1 | 2cmlC-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_C_ZMRC3477_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.23A | 2cmlC-4hzzA:62.9 | 2cmlC-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.61A | 2cmlD-4b7jA:64.1 | 2cmlD-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.60A | 2cmlD-4hzzA:62.8 | 2cmlD-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.41A | 2cmlD-4hzzA:62.8 | 2cmlD-4hzzA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.88A | 2cmlD-4hzzA:62.8 | 2cmlD-4hzzA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.72A | 2cmlD-4yw5A:20.4 | 2cmlD-4yw5A:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CML_D_ZMRD4477_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 2cmlD-6eksA:11.6 | 2cmlD-6eksA:21.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.23A | 2cmlD-4b7jA:64.1 | 2cmlD-4b7jA:38.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2CML_D_ZMRD4477_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.20A | 2cmlD-4hzzA:62.8 | 2cmlD-4hzzA:50.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.44A | 2f0zA-4b7jA:21.4 | 2f0zA-4b7jA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 156GLU A 278ARG A 293ARG A 368TYR A 402 | NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.11A | 2f0zA-4b7jA:21.4 | 2f0zA-4b7jA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.38A | 2f0zA-4hzzA:8.2 | 2f0zA-4hzzA:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 156GLU A 277ARG A 292ARG A 371TYR A 406 | NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 1.03A | 2f0zA-4hzzA:8.2 | 2f0zA-4hzzA:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290TYR A 553GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneG39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.37A | 2f0zA-4yw5A:38.1 | 2f0zA-4yw5A:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F0Z_A_ZMRA381_1 (SIALIDASE 2) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250GLU A 269GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 ( 4.7A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.29A | 2f0zA-6eksA:40.4 | 2f0zA-6eksA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.47A | 2f10A-4b7jA:9.5 | 2f10A-4b7jA:23.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.40A | 2f10A-4hzzA:8.4 | 2f10A-4hzzA:20.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 8 / 12 | ARG A 290ILE A 291ARG A 309TYR A 553GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneG39 A 801 (-4.3A)NoneG39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.59A | 2f10A-4yw5A:37.2 | 2f10A-4yw5A:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F10_A_BCZA382_0 (SIALIDASE 2) |
6eks | SIALIDASE (Vibriocholerae) | 8 / 12 | ARG A 250ILE A 251GLU A 269ARG A 271GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.7A)G39 A 908 (-4.2A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.43A | 2f10A-6eksA:39.4 | 2f10A-6eksA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GVC_B_MMZB501_1 (MONOOXYGENASE) |
6eks | SIALIDASE (Vibriocholerae) | 3 / 3 | ASN A 571TYR A 766SER A 644 | G39 A 908 (-4.5A)G39 A 908 (-4.6A)G39 A 908 ( 3.8A) | 0.78A | 2gvcB-6eksA:undetectable | 2gvcB-6eksA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GVC_E_MMZE501_1 (MONOOXYGENASE) |
6eks | SIALIDASE (Vibriocholerae) | 3 / 3 | ASN A 571TYR A 766SER A 644 | G39 A 908 (-4.5A)G39 A 908 (-4.6A)G39 A 908 ( 3.8A) | 0.78A | 2gvcE-6eksA:undetectable | 2gvcE-6eksA:20.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 152ARG A 156GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.9A)NoneNoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.67A | 2htqA-4b7jA:67.2 | 2htqA-4b7jA:53.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.13A | 2htqA-4b7jA:67.2 | 2htqA-4b7jA:53.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ARG A 152ARG A 156GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.72A | 2htqA-4hzzA:62.3 | 2htqA-4hzzA:45.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.69A | 2htqA-4yw5A:10.2 | 2htqA-4yw5A:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HTQ_A_ZMRA472_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.55A | 2htqA-6eksA:21.3 | 2htqA-6eksA:19.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTQ_A_ZMRA472_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151TRP A 178ILE A 222ARG A 224 | G39 A 509 (-3.6A)NoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A) | 0.37A | 2htqA-4hzzA:62.3 | 2htqA-4hzzA:45.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 179SER A 180ARG A 225GLU A 277ARG A 293TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneNoneG39 A1470 ( 4.5A)G39 A1470 (-4.4A)G39 A1470 (-3.7A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.44A | 2htuA-4b7jA:68.4 | 2htuA-4b7jA:53.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ILE A 222ARG A 224GLU A 276ARG A 292TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.5A)G39 A 509 ( 4.1A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.36A | 2htuA-4hzzA:63.3 | 2htuA-4hzzA:45.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 118ASP A 151GLU A 228ARG A 368 | G39 A1470 (-3.1A)G39 A1470 (-3.7A)NoneG39 A1470 (-3.0A) | 0.33A | 2htuA-4b7jA:68.4 | 2htuA-4b7jA:53.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2HTU_A_BCZA801_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 118ASP A 151GLU A 227ARG A 371 | G39 A 509 (-3.0A)G39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 0.28A | 2htuA-4hzzA:63.3 | 2htuA-4hzzA:45.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IGT_C_SAMC1003_1 (SAM DEPENDENTMETHYLTRANSFERASE) |
6eks | SIALIDASE (Vibriocholerae) | 4 / 4 | ASP A 315ASP A 276ASP A 285GLY A 274 | CA A 904 (-2.1A)G39 A 908 (-3.3A)NoneNone | 1.32A | 2igtC-6eksA:undetectable | 2igtC-6eksA:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OXT_B_SAMB300_1 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
6eks | SIALIDASE (Vibriocholerae) | 4 / 5 | SER A 253GLY A 575ASP A 373ASP A 318 | None CA A 903 ( 3.9A)NoneG39 A 908 ( 4.2A) | 1.13A | 2oxtB-6eksA:undetectable | 2oxtB-6eksA:15.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q63_A_1UNA1001_2 (PROTEASE RETROPEPSIN) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 3 / 3 | ARG A 662ASN A 725THR A 313 | G39 A 801 (-2.9A)NoneNone | 0.83A | 2q63A-4yw5A:undetectable | 2q63A-4yw5A:10.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7K_B_SALB1305_1 (LYSR-TYPE REGULATORYPROTEIN) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | ARG A 224PRO A 245GLY A 244TRP A 218 | G39 A 509 (-4.7A)NoneNoneNone | 1.33A | 2y7kB-4hzzA:undetectable | 2y7kB-4hzzA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290ASP A 307ILE A 371ASP A 388PHE A 316 | G39 A 801 (-2.6A)NoneNoneG39 A 801 ( 4.8A)GOL A 802 (-4.9A) | 0.83A | 2ya7A-4yw5A:42.9 | 2ya7A-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ILE A 291ASP A 307ILE A 320ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.9A)G39 A 801 (-4.4A) | 1.32A | 2ya7A-4yw5A:42.9 | 2ya7A-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 10 / 12 | ARG A 290ILE A 291ASP A 307ILE A 371ASP A 372ASP A 388TYR A 553ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.6A)G39 A 801 ( 4.8A)NoneG39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.38A | 2ya7A-4yw5A:42.9 | 2ya7A-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_A_ZMRA1776_1 (NEURAMINIDASE A) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ILE A 251ASP A 318ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.2A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.84A | 2ya7A-6eksA:43.2 | 2ya7A-6eksA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ILE A 291ASP A 307ILE A 320ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.9A)G39 A 801 (-4.4A) | 1.31A | 2ya7B-4yw5A:42.6 | 2ya7B-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 10 / 12 | ARG A 290ILE A 291ASP A 307ILE A 371ASP A 372ASP A 388TYR A 553ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.6A)G39 A 801 ( 4.8A)NoneG39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.36A | 2ya7B-4yw5A:42.6 | 2ya7B-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ILE A 291ASP A 307ILE A 371ASP A 388PHE A 316 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 ( 4.8A)GOL A 802 (-4.9A) | 0.78A | 2ya7B-4yw5A:42.6 | 2ya7B-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_B_ZMRB1776_1 (NEURAMINIDASE A) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ILE A 251ASP A 318ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.2A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.86A | 2ya7B-6eksA:43.0 | 2ya7B-6eksA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290ASP A 307ILE A 371ASP A 388PHE A 316 | G39 A 801 (-2.6A)NoneNoneG39 A 801 ( 4.8A)GOL A 802 (-4.9A) | 0.83A | 2ya7C-4yw5A:39.6 | 2ya7C-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ILE A 291ASP A 307ILE A 320ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.9A)G39 A 801 (-4.4A) | 1.30A | 2ya7C-4yw5A:39.6 | 2ya7C-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 10 / 12 | ARG A 290ILE A 291ASP A 307ILE A 371ASP A 372ASP A 388TYR A 553ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.6A)G39 A 801 ( 4.8A)NoneG39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.36A | 2ya7C-4yw5A:39.6 | 2ya7C-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ILE A 251ASP A 318ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.2A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.83A | 2ya7C-6eksA:41.2 | 2ya7C-6eksA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_C_ZMRC1776_1 (NEURAMINIDASE A) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ILE A 251ASP A 318LEU A 606ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.2A)NoneG39 A 908 (-3.0A)G39 A 908 (-4.6A) | 1.27A | 2ya7C-6eksA:41.2 | 2ya7C-6eksA:22.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ILE A 291ASP A 307ILE A 320ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.9A)G39 A 801 (-4.4A) | 1.31A | 2ya7D-4yw5A:19.6 | 2ya7D-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 10 / 12 | ARG A 290ILE A 291ASP A 307ILE A 371ASP A 372ASP A 388TYR A 553ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 (-2.6A)G39 A 801 ( 4.8A)NoneG39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.35A | 2ya7D-4yw5A:19.6 | 2ya7D-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ILE A 291ASP A 307ILE A 371ASP A 388PHE A 316 | G39 A 801 (-2.6A)NoneNoneNoneG39 A 801 ( 4.8A)GOL A 802 (-4.9A) | 0.78A | 2ya7D-4yw5A:19.6 | 2ya7D-4yw5A:24.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YA7_D_ZMRD1776_1 (NEURAMINIDASE A) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ILE A 251ASP A 318ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.2A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.83A | 2ya7D-6eksA:43.0 | 2ya7D-6eksA:22.19 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.55A | 3b7eA-4b7jA:74.5 | 3b7eA-4b7jA:82.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 228SER A 247ARG A 293ASN A 295TYR A 402 | NoneG39 A1470 ( 4.3A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 1.26A | 3b7eA-4b7jA:74.5 | 3b7eA-4b7jA:82.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.56A | 3b7eA-4hzzA:63.6 | 3b7eA-4hzzA:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.28A | 3b7eA-4hzzA:63.6 | 3b7eA-4hzzA:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.94A | 3b7eA-4hzzA:63.6 | 3b7eA-4hzzA:46.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.80A | 3b7eA-4yw5A:20.4 | 3b7eA-4yw5A:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_A_ZMRA1001_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.47A | 3b7eA-6eksA:20.8 | 3b7eA-6eksA:20.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_A_ZMRA1001_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.12A | 3b7eA-4hzzA:63.6 | 3b7eA-4hzzA:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.55A | 3b7eB-4b7jA:74.4 | 3b7eB-4b7jA:82.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.55A | 3b7eB-4hzzA:63.7 | 3b7eB-4hzzA:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.28A | 3b7eB-4hzzA:63.7 | 3b7eB-4hzzA:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.94A | 3b7eB-4hzzA:63.7 | 3b7eB-4hzzA:46.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.80A | 3b7eB-4yw5A:20.8 | 3b7eB-4yw5A:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B7E_B_ZMRB1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.48A | 3b7eB-6eksA:20.7 | 3b7eB-6eksA:20.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3B7E_B_ZMRB1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.13A | 3b7eB-4hzzA:63.7 | 3b7eB-4hzzA:46.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118ARG A 152GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.9A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.63A | 3ckzA-4b7jA:74.2 | 3ckzA-4b7jA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 152GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.39A | 3ckzA-4b7jA:74.2 | 3ckzA-4b7jA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.06A | 3ckzA-4b7jA:74.2 | 3ckzA-4b7jA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | ARG A 118GLU A 119ARG A 152GLU A 227GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.76A | 3ckzA-4hzzA:63.8 | 3ckzA-4hzzA:46.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 152GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.9A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.21A | 3ckzA-4hzzA:63.8 | 3ckzA-4hzzA:46.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 152GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.05A | 3ckzA-4hzzA:63.8 | 3ckzA-4hzzA:46.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.43A | 3ckzA-4yw5A:12.1 | 3ckzA-4yw5A:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CKZ_A_ZMRA469_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.32A | 3ckzA-6eksA:21.0 | 3ckzA-6eksA:22.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 6 | ASP A 151ARG A 156TRP A 179ARG A 225SER A 247 | G39 A1470 (-3.7A)NoneNoneG39 A1470 (-4.4A)G39 A1470 ( 4.3A) | 0.74A | 3ckzA-4b7jA:74.2 | 3ckzA-4b7jA:90.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CKZ_A_ZMRA469_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 6 | ASP A 151ARG A 156TRP A 178ILE A 222ARG A 224 | G39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A) | 0.67A | 3ckzA-4hzzA:63.8 | 3ckzA-4hzzA:46.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HCR_A_CHDA424_0 (FERROCHELATASE,MITOCHONDRIAL) |
6eks | SIALIDASE (Vibriocholerae) | 4 / 8 | LEU A 601ARG A 347GLY A 278PRO A 277 | NoneNone CA A 904 ( 4.6A)G39 A 908 ( 4.4A) | 1.04A | 3hcrA-6eksA:undetectable | 3hcrA-6eksA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HRD_E_NIOE5660_1 (NICOTINATEDEHYDROGENASE LARGEMOLYBDOPTERINSUBUNITNICOTINATEDEHYDROGENASE MEDIUMMOLYBDOPTERINSUBUNIT) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | GLU A 228GLU A 278TRP A 423 | NoneG39 A1470 (-4.2A)None | 0.95A | 3hrdA-4b7jA:undetectable3hrdE-4b7jA:undetectable3hrdF-4b7jA:undetectable | 3hrdA-4b7jA:19.603hrdE-4b7jA:19.603hrdF-4b7jA:20.59 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 156TRP A 179ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneNoneNoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.44A | 3k37A-4b7jA:53.2 | 3k37A-4b7jA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 156TRP A 178ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneNoneNoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.46A | 3k37A-4hzzA:52.4 | 3k37A-4hzzA:34.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_A_BCZA468_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250TRP A 337GLU A 645ARG A 661TYR A 766 | G39 A 908 (-2.8A)NoneG39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 0.58A | 3k37A-6eksA:13.8 | 3k37A-6eksA:19.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ARG A 368 | G39 A1470 (-3.7A)G39 A1470 (-3.9A)G39 A1470 (-3.0A) | 0.24A | 3k37A-4b7jA:53.2 | 3k37A-4b7jA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_A_BCZA468_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ASP A 151ARG A 152ARG A 371 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 (-2.9A) | 0.23A | 3k37A-4hzzA:52.4 | 3k37A-4hzzA:34.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118ASP A 151ARG A 156TRP A 179ARG A 223 | G39 A1470 (-3.1A)G39 A1470 (-3.7A)NoneNoneG39 A1470 (-4.0A) | 1.36A | 3k37B-4b7jA:53.1 | 3k37B-4b7jA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 156TRP A 179ARG A 225GLU A 228GLU A 278ARG A 293ARG A 368 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)NoneNoneG39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A) | 0.42A | 3k37B-4b7jA:53.1 | 3k37B-4b7jA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 156TRP A 178ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneNoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A) | 0.43A | 3k37B-4hzzA:52.3 | 3k37B-4hzzA:34.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A) | 0.79A | 3k37B-4yw5A:23.2 | 3k37B-4yw5A:20.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K37_B_BCZB468_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276TRP A 337GLU A 645ARG A 661ARG A 738 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)NoneG39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A) | 0.69A | 3k37B-6eksA:13.7 | 3k37B-6eksA:19.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152GLU A 277TYR A 402 | G39 A1470 (-3.9A)G39 A1470 (-3.7A)G39 A1470 (-4.5A) | 0.77A | 3k37B-4b7jA:53.1 | 3k37B-4b7jA:33.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K37_B_BCZB468_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152GLU A 276TYR A 406 | G39 A 509 (-3.9A)G39 A 509 ( 4.1A)G39 A 509 (-4.6A) | 0.91A | 3k37B-4hzzA:52.3 | 3k37B-4hzzA:34.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.60A | 3k39A-4b7jA:52.5 | 3k39A-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.35A | 3k39A-4b7jA:52.5 | 3k39A-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_A_BCZA1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.58A | 3k39A-4hzzA:51.8 | 3k39A-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.59A | 3k39B-4b7jA:52.6 | 3k39B-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.34A | 3k39B-4b7jA:52.6 | 3k39B-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.56A | 3k39B-4hzzA:51.9 | 3k39B-4hzzA:34.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.73A | 3k39B-4yw5A:23.8 | 3k39B-4yw5A:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_B_BCZB1001_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 0.43A | 3k39B-6eksA:6.3 | 3k39B-6eksA:19.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A) | 0.60A | 3k39C-4b7jA:52.5 | 3k39C-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A) | 0.59A | 3k39C-4hzzA:51.9 | 3k39C-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.40A | 3k39C-4hzzA:51.9 | 3k39C-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_C_BCZC1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 1.48A | 3k39C-4hzzA:51.9 | 3k39C-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293ARG A 368 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A) | 1.30A | 3k39D-4b7jA:52.5 | 3k39D-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A) | 0.61A | 3k39D-4b7jA:52.5 | 3k39D-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_D_BCZD1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A) | 0.60A | 3k39D-4hzzA:51.9 | 3k39D-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.61A | 3k39E-4b7jA:52.5 | 3k39E-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.34A | 3k39E-4b7jA:52.5 | 3k39E-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_E_BCZE1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.58A | 3k39E-4hzzA:51.9 | 3k39E-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.60A | 3k39F-4b7jA:52.5 | 3k39F-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.34A | 3k39F-4b7jA:52.5 | 3k39F-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_F_BCZF1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.57A | 3k39F-4hzzA:51.9 | 3k39F-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.60A | 3k39G-4b7jA:52.5 | 3k39G-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.32A | 3k39G-4b7jA:52.5 | 3k39G-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_G_BCZG1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.58A | 3k39G-4hzzA:51.9 | 3k39G-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.60A | 3k39H-4b7jA:52.5 | 3k39H-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.33A | 3k39H-4b7jA:52.5 | 3k39H-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_H_BCZH1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.57A | 3k39H-4hzzA:51.9 | 3k39H-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A) | 0.61A | 3k39I-4b7jA:52.5 | 3k39I-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A) | 0.59A | 3k39I-4hzzA:51.8 | 3k39I-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.39A | 3k39I-4hzzA:51.8 | 3k39I-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_I_BCZI1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 1.47A | 3k39I-4hzzA:51.8 | 3k39I-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A) | 0.60A | 3k39J-4b7jA:52.5 | 3k39J-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A) | 0.58A | 3k39J-4hzzA:51.9 | 3k39J-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.37A | 3k39J-4hzzA:51.9 | 3k39J-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_J_BCZJ1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 1.48A | 3k39J-4hzzA:51.9 | 3k39J-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A) | 0.60A | 3k39K-4b7jA:52.5 | 3k39K-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A) | 0.58A | 3k39K-4hzzA:51.9 | 3k39K-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.39A | 3k39K-4hzzA:51.9 | 3k39K-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_K_BCZK1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 1.48A | 3k39K-4hzzA:51.9 | 3k39K-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A) | 0.61A | 3k39L-4b7jA:52.6 | 3k39L-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A) | 0.59A | 3k39L-4hzzA:51.9 | 3k39L-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.39A | 3k39L-4hzzA:51.9 | 3k39L-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_L_BCZL1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 1.49A | 3k39L-4hzzA:51.9 | 3k39L-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.61A | 3k39M-4b7jA:52.6 | 3k39M-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 1.35A | 3k39M-4b7jA:52.6 | 3k39M-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_M_BCZM1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.57A | 3k39M-4hzzA:51.9 | 3k39M-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.24A | 3k39N-4b7jA:52.6 | 3k39N-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.60A | 3k39N-4b7jA:52.6 | 3k39N-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_N_BCZN1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.58A | 3k39N-4hzzA:51.9 | 3k39N-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.61A | 3k39O-4b7jA:52.5 | 3k39O-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 228GLU A 278ARG A 368TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.17A | 3k39O-4b7jA:52.5 | 3k39O-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.56A | 3k39O-4hzzA:51.9 | 3k39O-4hzzA:34.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K39_O_BCZO1001_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 738GLU A 782GLU A 269ARG A 661TYR A 766 | G39 A 908 (-3.0A)NoneG39 A 908 ( 4.7A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 1.40A | 3k39O-6eksA:13.8 | 3k39O-6eksA:19.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 152GLU A 119ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.9A)G39 A1470 (-3.5A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.49A | 3k39P-4b7jA:52.6 | 3k39P-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | ARG A 223GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.26A | 3k39P-4b7jA:52.6 | 3k39P-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.60A | 3k39P-4b7jA:52.6 | 3k39P-4b7jA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3K39_P_BCZP1001_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.59A | 3k39P-4hzzA:51.9 | 3k39P-4hzzA:34.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N2O_C_AG2C1002_1 (BIOSYNTHETICARGININEDECARBOXYLASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 8 | HIS A 275SER A 247ASP A 199ASP A 244 | NoneG39 A1470 ( 4.3A)NoneNone | 1.19A | 3n2oC-4b7jA:undetectable3n2oD-4b7jA:undetectable | 3n2oC-4b7jA:19.853n2oD-4b7jA:19.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P2K_A_SAMA6735_1 (16S RRNA METHYLASE) |
6eks | SIALIDASE (Vibriocholerae) | 3 / 3 | ASP A 318GLU A 782SER A 569 | G39 A 908 ( 4.2A)NoneNone | 0.67A | 3p2kA-6eksA:undetectable | 3p2kA-6eksA:14.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P2K_C_SAMC6735_1 (16S RRNA METHYLASE) |
6eks | SIALIDASE (Vibriocholerae) | 4 / 5 | ASN A 354ASP A 318GLU A 782SER A 569 | NoneG39 A 908 ( 4.2A)NoneNone | 1.30A | 3p2kC-6eksA:undetectable | 3p2kC-6eksA:14.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.56A | 3sanA-4b7jA:69.8 | 3sanA-4b7jA:48.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.58A | 3sanA-4hzzA:64.3 | 3sanA-4hzzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.35A | 3sanA-4hzzA:64.3 | 3sanA-4hzzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.91A | 3sanA-4hzzA:64.3 | 3sanA-4hzzA:45.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.44A | 3sanA-4yw5A:3.3 | 3sanA-4yw5A:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_A_ZMRA901_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 3sanA-6eksA:21.5 | 3sanA-6eksA:20.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | ASP A 151ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNone | 0.13A | 3sanA-4b7jA:69.8 | 3sanA-4b7jA:48.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_A_ZMRA901_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.16A | 3sanA-4hzzA:64.3 | 3sanA-4hzzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.55A | 3sanB-4b7jA:69.7 | 3sanB-4b7jA:48.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.57A | 3sanB-4hzzA:64.2 | 3sanB-4hzzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.34A | 3sanB-4hzzA:64.2 | 3sanB-4hzzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.90A | 3sanB-4hzzA:64.2 | 3sanB-4hzzA:45.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.44A | 3sanB-4yw5A:10.3 | 3sanB-4yw5A:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SAN_B_ZMRB901_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 3sanB-6eksA:21.6 | 3sanB-6eksA:20.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | ASP A 151ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNone | 0.13A | 3sanB-4b7jA:69.7 | 3sanB-4b7jA:48.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SAN_B_ZMRB901_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.17A | 3sanB-4hzzA:64.2 | 3sanB-4hzzA:45.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.54A | 3ti5A-4b7jA:75.7 | 3ti5A-4b7jA:98.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 228SER A 247ARG A 293ASN A 295TYR A 402 | NoneG39 A1470 ( 4.3A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 1.26A | 3ti5A-4b7jA:75.7 | 3ti5A-4b7jA:98.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.57A | 3ti5A-4hzzA:63.7 | 3ti5A-4hzzA:47.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.28A | 3ti5A-4hzzA:63.7 | 3ti5A-4hzzA:47.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.96A | 3ti5A-4hzzA:63.7 | 3ti5A-4hzzA:47.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.75A | 3ti5A-4yw5A:4.5 | 3ti5A-4yw5A:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_A_ZMRA1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.43A | 3ti5A-6eksA:20.9 | 3ti5A-6eksA:20.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_A_ZMRA1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.18A | 3ti5A-4hzzA:63.7 | 3ti5A-4hzzA:47.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.54A | 3ti5B-4b7jA:75.8 | 3ti5B-4b7jA:98.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 228SER A 247ARG A 293ASN A 295TYR A 402 | NoneG39 A1470 ( 4.3A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 1.25A | 3ti5B-4b7jA:75.8 | 3ti5B-4b7jA:98.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.56A | 3ti5B-4hzzA:63.7 | 3ti5B-4hzzA:47.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.28A | 3ti5B-4hzzA:63.7 | 3ti5B-4hzzA:47.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.95A | 3ti5B-4hzzA:63.7 | 3ti5B-4hzzA:47.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.77A | 3ti5B-4yw5A:9.9 | 3ti5B-4yw5A:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TI5_B_ZMRB1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 3ti5B-6eksA:20.9 | 3ti5B-6eksA:20.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TI5_B_ZMRB1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.16A | 3ti5B-4hzzA:63.7 | 3ti5B-4hzzA:47.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151TRP A 179GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneNoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.61A | 3ticA-4b7jA:64.0 | 3ticA-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151TRP A 179GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneNoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.45A | 3ticA-4b7jA:64.0 | 3ticA-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151TRP A 178GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.59A | 3ticA-4hzzA:64.7 | 3ticA-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151TRP A 178GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.37A | 3ticA-4hzzA:64.7 | 3ticA-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151TRP A 178GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.87A | 3ticA-4hzzA:64.7 | 3ticA-4hzzA:45.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.69A | 3ticA-4yw5A:7.5 | 3ticA-4yw5A:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_A_ZMRA1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 7 / 12 | ARG A 250ASP A 276TRP A 337GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)NoneG39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.65A | 3ticA-6eksA:21.0 | 3ticA-6eksA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 152ARG A 156ARG A 225 | NoneG39 A1470 (-3.9A)NoneG39 A1470 (-4.4A) | 0.26A | 3ticA-4b7jA:64.0 | 3ticA-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_A_ZMRA1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156ILE A 222ARG A 224 | NoneG39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A) | 0.18A | 3ticA-4hzzA:64.7 | 3ticA-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.62A | 3ticB-4b7jA:63.9 | 3ticB-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.46A | 3ticB-4b7jA:63.9 | 3ticB-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.58A | 3ticB-4hzzA:64.6 | 3ticB-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.38A | 3ticB-4hzzA:64.6 | 3ticB-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.87A | 3ticB-4hzzA:64.6 | 3ticB-4hzzA:45.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.72A | 3ticB-4yw5A:20.5 | 3ticB-4yw5A:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_B_ZMRB1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.47A | 3ticB-6eksA:21.0 | 3ticB-6eksA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_B_ZMRB1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.11A | 3ticB-4hzzA:64.6 | 3ticB-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.63A | 3ticC-4b7jA:63.9 | 3ticC-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.47A | 3ticC-4b7jA:63.9 | 3ticC-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.58A | 3ticC-4hzzA:64.8 | 3ticC-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.37A | 3ticC-4hzzA:64.8 | 3ticC-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.87A | 3ticC-4hzzA:64.8 | 3ticC-4hzzA:45.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.70A | 3ticC-4yw5A:20.4 | 3ticC-4yw5A:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_C_ZMRC1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 3ticC-6eksA:20.9 | 3ticC-6eksA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_C_ZMRC1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.12A | 3ticC-4hzzA:64.8 | 3ticC-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.63A | 3ticD-4b7jA:64.0 | 3ticD-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.46A | 3ticD-4b7jA:64.0 | 3ticD-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.58A | 3ticD-4hzzA:64.7 | 3ticD-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.37A | 3ticD-4hzzA:64.7 | 3ticD-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.86A | 3ticD-4hzzA:64.7 | 3ticD-4hzzA:45.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.70A | 3ticD-4yw5A:20.6 | 3ticD-4yw5A:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TIC_D_ZMRD1002_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 3ticD-6eksA:20.9 | 3ticD-6eksA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.16A | 3ticD-4b7jA:64.0 | 3ticD-4b7jA:45.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TIC_D_ZMRD1002_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 152ARG A 156TRP A 178ILE A 222 | NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.14A | 3ticD-4hzzA:64.7 | 3ticD-4hzzA:45.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.52A | 4b7nA-4b7jA:75.4 | 4b7nA-4b7jA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.55A | 4b7nA-4hzzA:63.3 | 4b7nA-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.93A | 4b7nA-4hzzA:63.3 | 4b7nA-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.77A | 4b7nA-4yw5A:11.8 | 4b7nA-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.46A | 4b7nA-6eksA:12.4 | 4b7nA-6eksA:22.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7N_A_ZMRA601_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 738GLU A 782GLU A 269ARG A 661TYR A 766 | G39 A 908 (-3.0A)NoneG39 A 908 ( 4.7A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 1.43A | 4b7nA-6eksA:12.4 | 4b7nA-6eksA:22.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.9A)NoneNone | 0.11A | 4b7nA-4b7jA:75.4 | 4b7nA-4b7jA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7N_A_ZMRA601_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.9A)NoneNone | 0.09A | 4b7nA-4hzzA:63.3 | 4b7nA-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.58A | 4b7qA-4b7jA:75.0 | 4b7qA-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.60A | 4b7qA-4hzzA:63.3 | 4b7qA-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.32A | 4b7qA-4hzzA:63.3 | 4b7qA-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.96A | 4b7qA-4hzzA:63.3 | 4b7qA-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.87A | 4b7qA-4yw5A:12.5 | 4b7qA-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_A_ZMRA601_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.57A | 4b7qA-6eksA:21.0 | 4b7qA-6eksA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_A_ZMRA601_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | G39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A) | 0.22A | 4b7qA-4hzzA:63.3 | 4b7qA-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.60A | 4b7qB-4b7jA:74.9 | 4b7qB-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.60A | 4b7qB-4hzzA:63.2 | 4b7qB-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.96A | 4b7qB-4hzzA:63.2 | 4b7qB-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.80A | 4b7qB-4yw5A:3.0 | 4b7qB-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_B_ZMRB601_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.51A | 4b7qB-6eksA:11.6 | 4b7qB-6eksA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.9A)NoneNone | 0.17A | 4b7qB-4b7jA:74.9 | 4b7qB-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_B_ZMRB601_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152ARG A 156TRP A 178 | NoneG39 A 509 (-3.9A)NoneNone | 0.20A | 4b7qB-4hzzA:63.2 | 4b7qB-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.58A | 4b7qC-4b7jA:75.0 | 4b7qC-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | GLU A 228SER A 247ARG A 293ASN A 295TYR A 402 | NoneG39 A1470 ( 4.3A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 1.31A | 4b7qC-4b7jA:75.0 | 4b7qC-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.57A | 4b7qC-4hzzA:63.1 | 4b7qC-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.99A | 4b7qC-4hzzA:63.1 | 4b7qC-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.77A | 4b7qC-4yw5A:11.9 | 4b7qC-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_C_ZMRC601_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.48A | 4b7qC-6eksA:12.5 | 4b7qC-6eksA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_C_ZMRC601_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156ILE A 222 | G39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A) | 0.24A | 4b7qC-4hzzA:63.1 | 4b7qC-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228SER A 247GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 ( 4.3A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.60A | 4b7qD-4b7jA:74.6 | 4b7qD-4b7jA:99.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.62A | 4b7qD-4hzzA:63.3 | 4b7qD-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.34A | 4b7qD-4hzzA:63.3 | 4b7qD-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.98A | 4b7qD-4hzzA:63.3 | 4b7qD-4hzzA:40.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.84A | 4b7qD-4yw5A:11.9 | 4b7qD-4yw5A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B7Q_D_ZMRD601_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.50A | 4b7qD-6eksA:20.9 | 4b7qD-6eksA:22.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4B7Q_D_ZMRD601_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.28A | 4b7qD-4hzzA:63.3 | 4b7qD-4hzzA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.65A | 4cpnA-4b7jA:53.2 | 4cpnA-4b7jA:34.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.64A | 4cpnA-4hzzA:52.5 | 4cpnA-4hzzA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.54A | 4cpnA-4hzzA:52.5 | 4cpnA-4hzzA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.01A | 4cpnA-4hzzA:52.5 | 4cpnA-4hzzA:30.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.78A | 4cpnA-4yw5A:23.9 | 4cpnA-4yw5A:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_A_ZMRA700_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.52A | 4cpnA-6eksA:24.9 | 4cpnA-6eksA:21.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_A_ZMRA700_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ARG A 152ARG A 156TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A) | 0.14A | 4cpnA-4hzzA:52.5 | 4cpnA-4hzzA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.64A | 4cpnB-4b7jA:53.1 | 4cpnB-4b7jA:34.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.60A | 4cpnB-4hzzA:52.4 | 4cpnB-4hzzA:30.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.44A | 4cpnB-4hzzA:52.4 | 4cpnB-4hzzA:30.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.81A | 4cpnB-4yw5A:3.3 | 4cpnB-4yw5A:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPN_B_ZMRB700_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.49A | 4cpnB-6eksA:25.0 | 4cpnB-6eksA:21.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.73A | 4cpzA-4b7jA:52.9 | 4cpzA-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.47A | 4cpzA-4b7jA:52.9 | 4cpzA-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.72A | 4cpzA-4hzzA:52.3 | 4cpzA-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.53A | 4cpzA-4hzzA:52.3 | 4cpzA-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.01A | 4cpzA-4hzzA:52.3 | 4cpzA-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.43A | 4cpzA-4yw5A:24.0 | 4cpzA-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 4cpzA-6eksA:24.9 | 4cpzA-6eksA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_A_ZMRA1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250LEU A 606GLU A 645ARG A 738TYR A 766 | G39 A 908 (-2.8A)NoneG39 A 908 (-4.0A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 1.22A | 4cpzA-6eksA:24.9 | 4cpzA-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 179 | NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNone | 0.19A | 4cpzA-4b7jA:52.9 | 4cpzA-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_A_ZMRA1471_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178 | NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNone | 0.14A | 4cpzA-4hzzA:52.3 | 4cpzA-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.67A | 4cpzB-4b7jA:52.8 | 4cpzB-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.48A | 4cpzB-4b7jA:52.8 | 4cpzB-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.66A | 4cpzB-4hzzA:52.1 | 4cpzB-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.51A | 4cpzB-4hzzA:52.1 | 4cpzB-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.00A | 4cpzB-4hzzA:52.1 | 4cpzB-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.41A | 4cpzB-4yw5A:23.9 | 4cpzB-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.31A | 4cpzB-6eksA:6.7 | 4cpzB-6eksA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_B_ZMRB1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250LEU A 606GLU A 645ARG A 738TYR A 766 | G39 A 908 (-2.8A)NoneG39 A 908 (-4.0A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 1.25A | 4cpzB-6eksA:6.7 | 4cpzB-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNone | 0.19A | 4cpzB-4b7jA:52.8 | 4cpzB-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_B_ZMRB1471_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNone | 0.19A | 4cpzB-4hzzA:52.1 | 4cpzB-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.61A | 4cpzC-4b7jA:52.9 | 4cpzC-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.64A | 4cpzC-4hzzA:52.2 | 4cpzC-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.48A | 4cpzC-4hzzA:52.2 | 4cpzC-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.29A | 4cpzC-4hzzA:52.2 | 4cpzC-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A) | 1.04A | 4cpzC-4hzzA:52.2 | 4cpzC-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.92A | 4cpzC-4hzzA:52.2 | 4cpzC-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.79A | 4cpzC-4yw5A:7.3 | 4cpzC-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.49A | 4cpzC-6eksA:13.7 | 4cpzC-6eksA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_C_ZMRC1470_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 738GLU A 782GLU A 269ARG A 661TYR A 766 | G39 A 908 (-3.0A)NoneG39 A 908 ( 4.7A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 1.48A | 4cpzC-6eksA:13.7 | 4cpzC-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.9A)NoneNone | 0.18A | 4cpzC-4b7jA:52.9 | 4cpzC-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_C_ZMRC1470_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.9A)NoneNone | 0.16A | 4cpzC-4hzzA:52.2 | 4cpzC-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.71A | 4cpzD-4b7jA:52.7 | 4cpzD-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.51A | 4cpzD-4b7jA:52.7 | 4cpzD-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.67A | 4cpzD-4hzzA:52.1 | 4cpzD-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.49A | 4cpzD-4hzzA:52.1 | 4cpzD-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 1.00A | 4cpzD-4hzzA:52.1 | 4cpzD-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.35A | 4cpzD-4yw5A:24.0 | 4cpzD-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 4cpzD-6eksA:13.8 | 4cpzD-6eksA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_D_ZMRD1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250LEU A 606GLU A 645ARG A 738TYR A 766 | G39 A 908 (-2.8A)NoneG39 A 908 (-4.0A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 1.24A | 4cpzD-6eksA:13.8 | 4cpzD-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNone | 0.16A | 4cpzD-4b7jA:52.7 | 4cpzD-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_D_ZMRD1471_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | ASP A 151ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNone | 0.15A | 4cpzD-4hzzA:52.0 | 4cpzD-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-4.5A) | 0.72A | 4cpzE-4b7jA:52.7 | 4cpzE-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.50A | 4cpzE-4b7jA:52.7 | 4cpzE-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.55A | 4cpzE-4hzzA:52.1 | 4cpzE-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.29A | 4cpzE-4hzzA:52.1 | 4cpzE-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.72A | 4cpzE-4hzzA:52.1 | 4cpzE-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.81A | 4cpzE-4yw5A:8.3 | 4cpzE-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.56A | 4cpzE-6eksA:13.8 | 4cpzE-6eksA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_E_ZMRE1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250LEU A 606GLU A 645ARG A 738TYR A 766 | G39 A 908 (-2.8A)NoneG39 A 908 (-4.0A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 1.24A | 4cpzE-6eksA:13.8 | 4cpzE-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.9A)NoneNone | 0.12A | 4cpzE-4b7jA:52.7 | 4cpzE-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_E_ZMRE1471_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.9A)NoneNone | 0.16A | 4cpzE-4hzzA:52.1 | 4cpzE-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.73A | 4cpzF-4b7jA:52.8 | 4cpzF-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.50A | 4cpzF-4b7jA:52.8 | 4cpzF-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.71A | 4cpzF-4hzzA:52.0 | 4cpzF-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.52A | 4cpzF-4hzzA:52.0 | 4cpzF-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.31A | 4cpzF-4hzzA:52.0 | 4cpzF-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 6 / 12 | GLU A 119ARG A 224GLU A 227GLU A 276GLU A 277ASN A 294 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A) | 1.14A | 4cpzF-4hzzA:52.0 | 4cpzF-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227GLU A 277ARG A 292ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.95A | 4cpzF-4hzzA:52.0 | 4cpzF-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.84A | 4cpzF-4yw5A:7.1 | 4cpzF-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_F_ZMRF1470_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.55A | 4cpzF-6eksA:25.0 | 4cpzF-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.9A)NoneNone | 0.16A | 4cpzF-4b7jA:52.8 | 4cpzF-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_F_ZMRF1470_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.9A)NoneNone | 0.09A | 4cpzF-4hzzA:52.0 | 4cpzF-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.68A | 4cpzG-4b7jA:52.5 | 4cpzG-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.44A | 4cpzG-4b7jA:52.5 | 4cpzG-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.69A | 4cpzG-4hzzA:52.0 | 4cpzG-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.46A | 4cpzG-4hzzA:52.0 | 4cpzG-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.37A | 4cpzG-4hzzA:52.0 | 4cpzG-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A) | 1.06A | 4cpzG-4hzzA:52.0 | 4cpzG-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.89A | 4cpzG-4hzzA:52.0 | 4cpzG-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.74A | 4cpzG-4yw5A:23.9 | 4cpzG-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_G_ZMRG1471_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.46A | 4cpzG-6eksA:13.8 | 4cpzG-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.9A)NoneNone | 0.18A | 4cpzG-4b7jA:52.5 | 4cpzG-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_G_ZMRG1471_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.9A)NoneNone | 0.12A | 4cpzG-4hzzA:52.0 | 4cpzG-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 277GLU A 278ASN A 295TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 ( 3.7A)G39 A1470 (-4.5A) | 0.76A | 4cpzH-4b7jA:52.7 | 4cpzH-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.57A | 4cpzH-4b7jA:52.7 | 4cpzH-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.71A | 4cpzH-4hzzA:52.0 | 4cpzH-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.53A | 4cpzH-4hzzA:52.0 | 4cpzH-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.35A | 4cpzH-4hzzA:52.0 | 4cpzH-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A) | 1.09A | 4cpzH-4hzzA:52.0 | 4cpzH-4hzzA:30.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 7 / 12 | GLU A 119ARG A 224GLU A 227ALA A 246GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.96A | 4cpzH-4hzzA:52.0 | 4cpzH-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.81A | 4cpzH-4yw5A:23.8 | 4cpzH-4yw5A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CPZ_H_ZMRH1470_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.56A | 4cpzH-6eksA:24.9 | 4cpzH-6eksA:20.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 179 | G39 A1470 (-3.9A)NoneNone | 0.20A | 4cpzH-4b7jA:52.7 | 4cpzH-4b7jA:33.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CPZ_H_ZMRH1470_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152ARG A 156TRP A 178 | G39 A 509 (-3.9A)NoneNone | 0.16A | 4cpzH-4hzzA:52.0 | 4cpzH-4hzzA:30.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FEW_D_KAND301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 8 | ASP A 388ASP A 315GLU A 584ASP A 307 | G39 A 801 ( 4.8A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)None | 1.21A | 4fewD-4yw5A:undetectable | 4fewD-4yw5A:18.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GKI_A_KANA301_1 (AMINOGLYCOSIDE3'-PHOSPHOTRANSFERASE APHA1-IAB) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 8 | ASP A 388ASP A 315GLU A 584ASP A 307 | G39 A 801 ( 4.8A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)None | 1.22A | 4gkiA-4yw5A:undetectable | 4gkiA-4yw5A:18.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | ARG A 118ASP A 151ARG A 152ARG A 225GLU A 228GLU A 277GLU A 278TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.7A)G39 A1470 (-3.9A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-4.5A) | 0.59A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 225GLU A 228GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-3.9A)G39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.42A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 223GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-4.0A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 1.08A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.45A | 4i00A-4hzzA:75.2 | 4i00A-4hzzA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ASP A 151ARG A 152ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.72A | 4i00A-4hzzA:75.2 | 4i00A-4hzzA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.74A | 4i00A-4yw5A:20.6 | 4i00A-4yw5A:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I00_A_ZMRA509_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.45A | 4i00A-6eksA:12.3 | 4i00A-6eksA:19.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ARG A 156TRP A 179ASN A 295 | NoneNoneNoneG39 A1470 ( 3.7A) | 0.95A | 4i00A-4b7jA:64.0 | 4i00A-4b7jA:40.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4I00_A_ZMRA509_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ARG A 156TRP A 178ILE A 222ASN A 294 | NoneNoneNoneG39 A 509 ( 4.1A)G39 A 509 ( 4.4A) | 0.19A | 4i00A-4hzzA:75.2 | 4i00A-4hzzA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KR3_A_GLYA701_0 (GLYCINE--TRNA LIGASE) |
6eks | SIALIDASE (Vibriocholerae) | 4 / 6 | ARG A 320GLU A 645ARG A 676SER A 644 | NoneG39 A 908 (-4.0A)NoneG39 A 908 ( 3.8A) | 1.35A | 4kr3A-6eksA:undetectable | 4kr3A-6eksA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LF7_A_PARA1817_1 (16S RRNARIBOSOMAL PROTEIN S9RIBOSOMAL PROTEINS10) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 3 / 3 | TYR A 695ARG A 662SER A 694 | G39 A 801 (-4.4A)G39 A 801 (-2.9A)None | 1.15A | 4lf7I-4yw5A:undetectable4lf7J-4yw5A:undetectable | 4lf7I-4yw5A:11.954lf7J-4yw5A:10.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LF8_A_PARA1817_1 (16S RRNARIBOSOMAL PROTEIN S9RIBOSOMAL PROTEINS10) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 3 / 3 | TYR A 695ARG A 662SER A 694 | G39 A 801 (-4.4A)G39 A 801 (-2.9A)None | 1.15A | 4lf8I-4yw5A:undetectable4lf8J-4yw5A:undetectable | 4lf8I-4yw5A:11.954lf8J-4yw5A:10.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.61A | 4mwrA-4b7jA:64.3 | 4mwrA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 156ARG A 225GLU A 228GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.43A | 4mwrA-4b7jA:64.3 | 4mwrA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.59A | 4mwrA-4hzzA:63.0 | 4mwrA-4hzzA:48.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.38A | 4mwrA-4hzzA:63.0 | 4mwrA-4hzzA:48.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 9 / 12 | GLU A 119ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.89A | 4mwrA-4hzzA:63.0 | 4mwrA-4hzzA:48.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.44A | 4mwrA-4yw5A:20.3 | 4mwrA-4yw5A:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWR_A_ZMRA513_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.35A | 4mwrA-6eksA:20.7 | 4mwrA-6eksA:19.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | LEU A 134ASP A 151ARG A 152TRP A 179 | NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)None | 0.26A | 4mwrA-4b7jA:64.3 | 4mwrA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWR_A_ZMRA513_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | LEU A 134ASP A 151ARG A 152TRP A 178ILE A 222 | NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A) | 0.19A | 4mwrA-4hzzA:63.0 | 4mwrA-4hzzA:48.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156TRP A 179ARG A 225GLU A 277GLU A 278ARG A 293TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneNoneG39 A1470 (-4.4A)G39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-4.5A) | 0.42A | 4mwvA-4b7jA:64.2 | 4mwvA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ASP A 151ARG A 152ILE A 222ARG A 224GLU A 227 | G39 A 509 (-3.6A)G39 A 509 (-3.9A)G39 A 509 ( 4.1A)G39 A 509 (-4.7A)None | 1.27A | 4mwvA-4hzzA:63.0 | 4mwvA-4hzzA:48.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224GLU A 276GLU A 277ARG A 292TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-4.6A) | 0.21A | 4mwvA-4hzzA:63.0 | 4mwvA-4hzzA:48.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWV_A_BCZA513_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ASP A 276TRP A 337GLU A 645ARG A 661TYR A 766 | G39 A 908 (-3.3A)NoneG39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-4.6A) | 0.58A | 4mwvA-6eksA:8.1 | 4mwvA-6eksA:19.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118GLU A 228ARG A 368 | G39 A1470 (-3.1A)NoneG39 A1470 (-3.0A) | 0.20A | 4mwvA-4b7jA:64.2 | 4mwvA-4b7jA:40.76 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWV_A_BCZA513_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118GLU A 227ARG A 371 | G39 A 509 (-3.0A)NoneG39 A 509 (-2.9A) | 0.20A | 4mwvA-4hzzA:63.0 | 4mwvA-4hzzA:48.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.62A | 4mwxA-4b7jA:64.2 | 4mwxA-4b7jA:40.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.61A | 4mwxA-4hzzA:63.0 | 4mwxA-4hzzA:48.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290ASP A 315GLU A 584ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.76A | 4mwxA-4yw5A:7.6 | 4mwxA-4yw5A:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MWX_A_ZMRA513_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250ASP A 276GLU A 645ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.47A | 4mwxA-6eksA:5.6 | 4mwxA-6eksA:18.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MWX_A_ZMRA513_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 152TRP A 178ILE A 222 | G39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A) | 0.14A | 4mwxA-4hzzA:63.0 | 4mwxA-4hzzA:48.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 179SER A 180ARG A 225GLU A 228GLU A 277GLU A 278TYR A 402 | G39 A1470 (-3.5A)NoneG39 A1470 (-3.9A)NoneNoneG39 A1470 ( 4.5A)G39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-4.5A) | 0.41A | 4mx0A-4b7jA:64.2 | 4mx0A-4b7jA:40.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 12 / 12 | GLU A 119LEU A 134ARG A 152ARG A 156TRP A 178SER A 179ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277TYR A 406 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.5A)G39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-4.6A) | 0.39A | 4mx0A-4hzzA:62.9 | 4mx0A-4hzzA:48.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ASP A 151ARG A 368 | G39 A1470 (-3.1A)G39 A1470 (-3.7A)G39 A1470 (-3.0A) | 0.23A | 4mx0A-4b7jA:64.2 | 4mx0A-4b7jA:40.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | ARG A 118ASP A 151ARG A 371 | G39 A 509 (-3.0A)G39 A 509 (-3.6A)G39 A 509 (-2.9A) | 0.19A | 4mx0A-4hzzA:62.9 | 4mx0A-4hzzA:48.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 3 / 3 | ARG A 290ASP A 315ARG A 662 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 (-2.9A) | 0.77A | 4mx0A-4yw5A:4.5 | 4mx0A-4yw5A:20.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MX0_A_BCZA513_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 3 / 3 | ARG A 250ASP A 276ARG A 738 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-3.0A) | 0.37A | 4mx0A-6eksA:6.0 | 4mx0A-6eksA:18.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4URO_A_NOVA2000_1 (DNA GYRASE SUBUNIT B) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | GLU A 269PRO A 574ASP A 647ILE A 599SER A 569 | G39 A 908 ( 4.7A) CA A 903 (-4.4A) CA A 903 (-2.1A)NoneNone | 1.19A | 4uroA-6eksA:undetectable | 4uroA-6eksA:15.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151GLU A 228GLU A 277GLU A 278ARG A 293ASN A 295ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 ( 3.7A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.69A | 4wa5A-4b7jA:67.8 | 4wa5A-4b7jA:49.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 10 / 12 | ARG A 118GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.66A | 4wa5A-4hzzA:62.1 | 4wa5A-4hzzA:47.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 8 / 12 | GLU A 119ASP A 151GLU A 227ALA A 246GLU A 276GLU A 277ASN A 294TYR A 406 | G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 ( 4.4A)G39 A 509 (-4.6A) | 0.95A | 4wa5A-4hzzA:62.1 | 4wa5A-4hzzA:47.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.44A | 4wa5A-4yw5A:10.3 | 4wa5A-4yw5A:20.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250ASP A 276ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.65A | 4wa5A-6eksA:3.7 | 4wa5A-6eksA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WA5_A_ZMRA501_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.34A | 4wa5A-6eksA:3.7 | 4wa5A-6eksA:20.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 4 / 5 | ARG A 152ARG A 156TRP A 179ARG A 225 | G39 A1470 (-3.9A)NoneNoneG39 A1470 (-4.4A) | 0.65A | 4wa5A-4b7jA:67.8 | 4wa5A-4b7jA:49.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4WA5_A_ZMRA501_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 5 | ARG A 152ARG A 156TRP A 178ILE A 222ARG A 224 | G39 A 509 (-3.9A)NoneNoneG39 A 509 ( 4.1A)G39 A 509 (-4.7A) | 0.54A | 4wa5A-4hzzA:62.1 | 4wa5A-4hzzA:47.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_A_KANA600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.47A | 5iqbA-4hzzA:undetectable | 5iqbA-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_B_KANB600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 11 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.46A | 5iqbB-4hzzA:undetectable | 5iqbB-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_C_KANC600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 11 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.47A | 5iqbC-4hzzA:0.5 | 5iqbC-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQB_D_KAND600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.47A | 5iqbD-4hzzA:undetectable | 5iqbD-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_A_51GA600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.46A | 5iqcA-4hzzA:0.5 | 5iqcA-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_B_51GB600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.48A | 5iqcB-4hzzA:0.8 | 5iqcB-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_C_51GC600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.48A | 5iqcC-4hzzA:0.8 | 5iqcC-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQC_D_51GD600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.47A | 5iqcD-4hzzA:0.0 | 5iqcD-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQE_A_NMYA600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 11 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.48A | 5iqeA-4hzzA:0.9 | 5iqeA-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQE_B_NMYB600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 10 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.48A | 5iqeB-4hzzA:0.8 | 5iqeB-4hzzA:22.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IQE_D_NMYD600_1 (BIFUNCTIONAL AAC/APH) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | SER A 179ASP A 198GLU A 119GLU A 277GLU A 227 | G39 A 509 ( 4.5A)NoneG39 A 509 (-3.3A)G39 A 509 ( 4.0A)None | 1.47A | 5iqeD-4hzzA:undetectable | 5iqeD-4hzzA:22.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.54A | 5l17A-4b7jA:64.5 | 5l17A-4b7jA:42.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.53A | 5l17A-4hzzA:63.0 | 5l17A-4hzzA:47.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 156ARG A 224GLU A 227ALA A 246GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.37A | 5l17A-4hzzA:63.0 | 5l17A-4hzzA:47.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ARG A 290ASP A 315GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.72A | 5l17A-4yw5A:7.7 | 5l17A-4yw5A:20.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L17_A_ZMRA512_1 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 12 | ARG A 250ASP A 276GLU A 645ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.44A | 5l17A-6eksA:20.6 | 5l17A-6eksA:19.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5L17_A_ZMRA512_2 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 4 / 4 | LEU A 134ARG A 152TRP A 178ILE A 222 | NoneG39 A 509 (-3.9A)NoneG39 A 509 ( 4.1A) | 0.15A | 5l17A-4hzzA:63.0 | 5l17A-4hzzA:47.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L66_K_BO2K301_1 (PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 10 | ALA A 342GLY A 355ALA A 335ASP A 318SER A 317 | NoneNoneNoneG39 A 908 ( 4.2A)G39 A 908 ( 4.6A) | 1.45A | 5l66K-6eksA:undetectable5l66L-6eksA:undetectable | 5l66K-6eksA:14.445l66L-6eksA:14.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L66_Y_BO2Y301_1 (PROTEASOME SUBUNITBETATYPE-8,PROTEASOMESUBUNIT BETA TYPE-5PROTEASOME SUBUNITBETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETATYPE-6,PROTEASOMESUBUNIT BETATYPE-1,PROTEASOMESUBUNIT BETA TYPE-6) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 10 | ALA A 342GLY A 355ALA A 335ASP A 318SER A 317 | NoneNoneNoneG39 A 908 ( 4.2A)G39 A 908 ( 4.6A) | 1.44A | 5l66Y-6eksA:undetectable5l66Z-6eksA:undetectable | 5l66Y-6eksA:14.445l66Z-6eksA:14.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M54_E_TA1E502_1 (TUBULIN BETA-2BCHAIN) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ALA A 709SER A 767PHE A 725ARG A 738GLY A 705 | NoneNoneNoneG39 A 908 (-3.0A)None | 1.15A | 5m54E-6eksA:undetectable | 5m54E-6eksA:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_A_ACRA1481_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 6 | SER A 696ARG A 290GLU A 711TYR A 695 | NoneG39 A 801 (-2.6A)NoneG39 A 801 (-4.4A) | 1.15A | 5x7pA-4yw5A:4.1 | 5x7pA-4yw5A:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7P_B_ACRB1481_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 6 | SER A 696ARG A 290GLU A 711TYR A 695 | NoneG39 A 801 (-2.6A)NoneG39 A 801 (-4.4A) | 1.20A | 5x7pB-4yw5A:4.2 | 5x7pB-4yw5A:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7Q_A_ACRA1481_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 6 | SER A 696ARG A 290GLU A 711TYR A 695 | NoneG39 A 801 (-2.6A)NoneG39 A 801 (-4.4A) | 1.19A | 5x7qA-4yw5A:4.0 | 5x7qA-4yw5A:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7Q_B_ACRB1481_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 6 | SER A 696ARG A 290GLU A 711TYR A 695 | NoneG39 A 801 (-2.6A)NoneG39 A 801 (-4.4A) | 1.18A | 5x7qB-4yw5A:4.2 | 5x7qB-4yw5A:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7R_A_ACRA1481_1 (GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 4 / 6 | SER A 696ARG A 290GLU A 711TYR A 695 | NoneG39 A 801 (-2.6A)NoneG39 A 801 (-4.4A) | 1.19A | 5x7rA-4yw5A:undetectable | 5x7rA-4yw5A:19.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 278ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-4.2A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.33A | 6ekuA-4b7jA:12.0 | 6ekuA-4b7jA:22.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 5 / 12 | ARG A 118GLU A 277ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.33A | 6ekuA-4hzzA:11.7 | 6ekuA-4hzzA:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 7 / 12 | ARG A 290ILE A 291ARG A 309GLU A 584ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)NoneG39 A 801 (-4.3A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.48A | 6ekuA-4yw5A:37.1 | 6ekuA-4yw5A:25.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 6 / 12 | ILE A 291ASP A 372GLU A 584ARG A 600ARG A 662TYR A 695 | NoneG39 A 801 (-2.6A)G39 A 801 ( 4.7A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.74A | 6ekuA-4yw5A:37.1 | 6ekuA-4yw5A:25.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EKU_A_ZMRA901_1 (SIALIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 12 / 12 | ARG A 250ILE A 251GLU A 269ARG A 271PRO A 277ASP A 318ASN A 344GLU A 645ARG A 661ASP A 663ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-4.7A)G39 A 908 ( 4.7A)G39 A 908 (-4.2A)G39 A 908 ( 4.4A)G39 A 908 ( 4.2A)G39 A 908 (-3.5A)G39 A 908 (-4.0A)G39 A 908 (-2.8A)G39 A 908 (-3.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.30A | 6ekuA-6eksA:71.0 | 6ekuA-6eksA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6EKU_A_ZMRA901_2 (SIALIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 6 / 6 | ASP A 276GLN A 343ASN A 571LEU A 606SER A 644PHE A 664 | G39 A 908 (-3.3A)G39 A 908 (-3.8A)G39 A 908 (-4.5A)NoneG39 A 908 ( 3.8A)None | 0.34A | 6ekuA-6eksA:71.0 | 6ekuA-6eksA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4b7j | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277ARG A 293ARG A 368TYR A 402 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)G39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-2.9A)G39 A1470 (-3.0A)G39 A1470 (-4.5A) | 0.59A | 6hcxA-4b7jA:64.4 | 6hcxA-4b7jA:10.72 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246ARG A 292ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 (-2.8A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.42A | 6hcxA-4hzzA:63.1 | 6hcxA-4hzzA:31.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 11 / 12 | ARG A 118GLU A 119ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276ARG A 371TYR A 406 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)G39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 (-2.9A)G39 A 509 (-4.6A) | 0.58A | 6hcxA-4hzzA:63.1 | 6hcxA-4hzzA:31.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
4yw5 | NEURAMINIDASE C (Streptococcuspneumoniae) | 5 / 12 | ARG A 290ASP A 315ARG A 600ARG A 662TYR A 695 | G39 A 801 (-2.6A)G39 A 801 (-3.2A)G39 A 801 (-2.9A)G39 A 801 (-2.9A)G39 A 801 (-4.4A) | 0.76A | 6hcxA-4yw5A:8.1 | 6hcxA-4yw5A:9.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HCX_A_ZMRA519_0 (NEURAMINIDASE) |
6eks | SIALIDASE (Vibriocholerae) | 5 / 12 | ARG A 250ASP A 276ARG A 661ARG A 738TYR A 766 | G39 A 908 (-2.8A)G39 A 908 (-3.3A)G39 A 908 (-2.8A)G39 A 908 (-3.0A)G39 A 908 (-4.6A) | 0.42A | 6hcxA-6eksA:20.7 | 6hcxA-6eksA:7.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6HCX_A_ZMRA519_1 (NEURAMINIDASE) |
4hzz | NEURAMINIDASE (InfluenzaAvirus) | 3 / 3 | TRP A 178ILE A 222GLU A 277 | NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 0.19A | 6hcxA-4hzzA:63.1 | 6hcxA-4hzzA:31.88 |